Novavax NVAX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novavax's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novavax's short-term investments?
- Novavax (NVAX) reported short-term investments of $561.97M in Q1 2026.
- How has Novavax's short-term investments changed year-over-year?
- Novavax's short-term investments increased by 20.0% year-over-year, from $468.14M to $561.97M.
- What is the long-term trend for Novavax's short-term investments?
- Over 4 years (2020 to 2025), Novavax's short-term investments has grown at a 33.1% compound annual growth rate (CAGR), from $157.65M to $494.45M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.